Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene

M. Jaskelioff, W. Song, J. Xia, C. Liu, J. Kramer, S. Koido, Sandra J Gendler, S. K. Calderwood, J. Gong

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Mice transgenic for MUC1 (mucin 1) and polyomavirus middle T (PyMT) develop mammary carcinomas within 15 weeks with 100% penetrance. PyMT-induced mammary tumorigenesis is closely correlated with robust telomerase expression and activity. To assess the role of telomerase activation and telomere maintenance in mammary carcinoma tumorigenesis, we generated mice expressing MUC1 and PyMT (MMT mice) but deficient in the telomerase RNA component, mTerc, on the C57BL/6 background. Successive generational intercrosses of mTerc / MMT mice produced cohorts with progressively shorter telomeres that were audited for mammary tumor formation. Relative to MMT (N14) and G0 mTerc / female controls (G014), mTerc / MMT females (G111, G215, G315 and G45) showed decreased tumor volumes and increased tumor latencyMMT95.6 days; G0 mTerc / MMT98.6 days versus G1, G2, G3 and G4 mTerc / MMT mice with latencies of 122.6, 138.9, 140.7 and 220.9 days, respectively (controls versus G1-G4, P0.005). The progressive impairment of lung metastasis was also observed with each successive mTerc / MMT generation. The impairment of tumorigenesis was associated with decreased proliferation of mammary epithelial and tumor cells and increased apoptosis of tumor cells. Together, these results indicate that, in the setting of viral oncoprotein mammary tumorigenesis, telomerase-dependent telomere maintenance facilitates the formation and metastatic progression of mammary tumors.

Original languageEnglish (US)
Pages (from-to)4225-4236
Number of pages12
JournalOncogene
Volume28
Issue number48
DOIs
StatePublished - Dec 2009

Fingerprint

Polyomavirus
Telomerase
Telomere
Oncogenes
Breast Neoplasms
Carcinogenesis
Mucin-1
Breast
Maintenance
Penetrance
Oncogene Proteins
Tumor Burden
Transgenic Mice
2-methylcyclopentadienyl manganese tricarbonyl
Neoplasms
Epithelial Cells
Apoptosis
Neoplasm Metastasis
Lung

Keywords

  • Mammary carcinoma
  • MUC1
  • PyMT
  • Telomerase
  • Telomeres

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Jaskelioff, M., Song, W., Xia, J., Liu, C., Kramer, J., Koido, S., ... Gong, J. (2009). Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. Oncogene, 28(48), 4225-4236. https://doi.org/10.1038/onc.2009.268

Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. / Jaskelioff, M.; Song, W.; Xia, J.; Liu, C.; Kramer, J.; Koido, S.; Gendler, Sandra J; Calderwood, S. K.; Gong, J.

In: Oncogene, Vol. 28, No. 48, 12.2009, p. 4225-4236.

Research output: Contribution to journalArticle

Jaskelioff, M, Song, W, Xia, J, Liu, C, Kramer, J, Koido, S, Gendler, SJ, Calderwood, SK & Gong, J 2009, 'Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene', Oncogene, vol. 28, no. 48, pp. 4225-4236. https://doi.org/10.1038/onc.2009.268
Jaskelioff, M. ; Song, W. ; Xia, J. ; Liu, C. ; Kramer, J. ; Koido, S. ; Gendler, Sandra J ; Calderwood, S. K. ; Gong, J. / Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene. In: Oncogene. 2009 ; Vol. 28, No. 48. pp. 4225-4236.
@article{8216475e15b644889d24ddc59b893114,
title = "Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene",
abstract = "Mice transgenic for MUC1 (mucin 1) and polyomavirus middle T (PyMT) develop mammary carcinomas within 15 weeks with 100{\%} penetrance. PyMT-induced mammary tumorigenesis is closely correlated with robust telomerase expression and activity. To assess the role of telomerase activation and telomere maintenance in mammary carcinoma tumorigenesis, we generated mice expressing MUC1 and PyMT (MMT mice) but deficient in the telomerase RNA component, mTerc, on the C57BL/6 background. Successive generational intercrosses of mTerc / MMT mice produced cohorts with progressively shorter telomeres that were audited for mammary tumor formation. Relative to MMT (N14) and G0 mTerc / female controls (G014), mTerc / MMT females (G111, G215, G315 and G45) showed decreased tumor volumes and increased tumor latencyMMT95.6 days; G0 mTerc / MMT98.6 days versus G1, G2, G3 and G4 mTerc / MMT mice with latencies of 122.6, 138.9, 140.7 and 220.9 days, respectively (controls versus G1-G4, P0.005). The progressive impairment of lung metastasis was also observed with each successive mTerc / MMT generation. The impairment of tumorigenesis was associated with decreased proliferation of mammary epithelial and tumor cells and increased apoptosis of tumor cells. Together, these results indicate that, in the setting of viral oncoprotein mammary tumorigenesis, telomerase-dependent telomere maintenance facilitates the formation and metastatic progression of mammary tumors.",
keywords = "Mammary carcinoma, MUC1, PyMT, Telomerase, Telomeres",
author = "M. Jaskelioff and W. Song and J. Xia and C. Liu and J. Kramer and S. Koido and Gendler, {Sandra J} and Calderwood, {S. K.} and J. Gong",
year = "2009",
month = "12",
doi = "10.1038/onc.2009.268",
language = "English (US)",
volume = "28",
pages = "4225--4236",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "48",

}

TY - JOUR

T1 - Telomerase deficiency and telomere dysfunction inhibit mammary tumors induced by polyomavirus middle T oncogene

AU - Jaskelioff, M.

AU - Song, W.

AU - Xia, J.

AU - Liu, C.

AU - Kramer, J.

AU - Koido, S.

AU - Gendler, Sandra J

AU - Calderwood, S. K.

AU - Gong, J.

PY - 2009/12

Y1 - 2009/12

N2 - Mice transgenic for MUC1 (mucin 1) and polyomavirus middle T (PyMT) develop mammary carcinomas within 15 weeks with 100% penetrance. PyMT-induced mammary tumorigenesis is closely correlated with robust telomerase expression and activity. To assess the role of telomerase activation and telomere maintenance in mammary carcinoma tumorigenesis, we generated mice expressing MUC1 and PyMT (MMT mice) but deficient in the telomerase RNA component, mTerc, on the C57BL/6 background. Successive generational intercrosses of mTerc / MMT mice produced cohorts with progressively shorter telomeres that were audited for mammary tumor formation. Relative to MMT (N14) and G0 mTerc / female controls (G014), mTerc / MMT females (G111, G215, G315 and G45) showed decreased tumor volumes and increased tumor latencyMMT95.6 days; G0 mTerc / MMT98.6 days versus G1, G2, G3 and G4 mTerc / MMT mice with latencies of 122.6, 138.9, 140.7 and 220.9 days, respectively (controls versus G1-G4, P0.005). The progressive impairment of lung metastasis was also observed with each successive mTerc / MMT generation. The impairment of tumorigenesis was associated with decreased proliferation of mammary epithelial and tumor cells and increased apoptosis of tumor cells. Together, these results indicate that, in the setting of viral oncoprotein mammary tumorigenesis, telomerase-dependent telomere maintenance facilitates the formation and metastatic progression of mammary tumors.

AB - Mice transgenic for MUC1 (mucin 1) and polyomavirus middle T (PyMT) develop mammary carcinomas within 15 weeks with 100% penetrance. PyMT-induced mammary tumorigenesis is closely correlated with robust telomerase expression and activity. To assess the role of telomerase activation and telomere maintenance in mammary carcinoma tumorigenesis, we generated mice expressing MUC1 and PyMT (MMT mice) but deficient in the telomerase RNA component, mTerc, on the C57BL/6 background. Successive generational intercrosses of mTerc / MMT mice produced cohorts with progressively shorter telomeres that were audited for mammary tumor formation. Relative to MMT (N14) and G0 mTerc / female controls (G014), mTerc / MMT females (G111, G215, G315 and G45) showed decreased tumor volumes and increased tumor latencyMMT95.6 days; G0 mTerc / MMT98.6 days versus G1, G2, G3 and G4 mTerc / MMT mice with latencies of 122.6, 138.9, 140.7 and 220.9 days, respectively (controls versus G1-G4, P0.005). The progressive impairment of lung metastasis was also observed with each successive mTerc / MMT generation. The impairment of tumorigenesis was associated with decreased proliferation of mammary epithelial and tumor cells and increased apoptosis of tumor cells. Together, these results indicate that, in the setting of viral oncoprotein mammary tumorigenesis, telomerase-dependent telomere maintenance facilitates the formation and metastatic progression of mammary tumors.

KW - Mammary carcinoma

KW - MUC1

KW - PyMT

KW - Telomerase

KW - Telomeres

UR - http://www.scopus.com/inward/record.url?scp=71349088358&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=71349088358&partnerID=8YFLogxK

U2 - 10.1038/onc.2009.268

DO - 10.1038/onc.2009.268

M3 - Article

VL - 28

SP - 4225

EP - 4236

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 48

ER -